Economic consequences of renal dysfunction among cardiopulmonary bypass surgery patients: A hospital-based perspective

Value in Health

Volumn 6, Issue 2, 2003, Pages 137-143

  Callahan, Mark ^a,b   Battleman, David S ^a,b   Christos, Paul ^a   Efimba, Maloke ^d   Whitelaw, George ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b New York Presbyterian Hosptial   (United States)

^c SMT Inc   (United States)

^d NONE

Author keywords

Cardiopulmonary bypass surgery; Economic evaluation; Outcomes research; Renal dysfunction

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOPULMONARY BYPASS; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEALTH ECONOMICS; HOSPITAL DEPARTMENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHARMACY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOLOGY; SEX DIFFERENCE; SURGICAL MORTALITY;

EID: 0037356132     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4733.2003.00211.x     Document Type: Article

References (30)

1. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas (TX): The Association, 2000.
2. Ugnat AM, Naylor CD. Trends in coronary artery bypass grafting in Ontario from 1981 to 1989. CMAJ 1993;148:569-75.
3. Platt GH, Svenson LW, Woodhead SE. Coronary artery bypass grafting in Alberta from 1984 to 1989. Can J Cardiol 1993;9:621-4.
4. Naylor CD, Ugnat AM, Weinkauf D, et al. Coronary artery bypass grafting in Canada: what is its rate of use? Which rate is right? CMAJ 1992; 146:851-9.
5. Haraphongse M, Na-Ayudhya RK, Teo KK, et al. The changing clinical profile of coronary artery bypass graft patients, 1970-89. Can J Cardiol 1994;10:71-6.
6. Anderson GM, Grumbach K, Luft HS, et al. Use of coronary artery bypass surgery in the United States and Canada: influence of age and income. JAMA 1993;269:1661-6.
7. Christakis GT, Ivanov J, Weisel RD, et al. The changing pattern of coronary artery bypass surgery. Circulation 1989;80:I151-61.
8. Peterson ED, Jollis JG, Bebchuk JD, et al. Changes in mortality after myocardial revascularization in the elderly: the national Medicare experience. Ann Intern Med 1994;121:919-27.
9. Peterson ED, Cowper PA, Jollis JG, et al. Outcomes of coronary artery bypass graft surgery in 24,461 patients aged 80 years or older. Circulation 1995;92:II85-91.
10. Abramov D, Tamariz MG, Fremes SE, et al. Trends in coronary artery bypass surgery results: a recent, 9-year study. Ann Thorac Surg 2000;70:84-90.
11. Shaw PJ, Bates D, Cartlidge NE, et al. Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery. Stroke 1987;18:700-7.
12. Jones EL, Weintraub WS, Craver JM, et al. Coronary bypass surgery: is the operation different today? J Thorac Cardiovasc Surg 1991;101: 108-15.
13. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84.
14. Hammermeister KE, Burchfiel C, Johnson R, Grover FL. Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation 1990;82:IV380-9.
15. Reves JG, Karp RB, Buttner EE, et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 1982;66:49-55.
16. Mazzarella V, Gallucci MT, Tozzo C, et al. Renal function in patients undergoing cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 1992;104:1625-7.
17. Mori A, Watanabe K, Onoe M, et al. Regional blood flow in the liver, pancreas and kidney during pulsatile and nonpulsatile perfusion under profound hypothermia. Jpn Circ J 1988;52:219-27.
18. Yeboah ED, Petrie A, Pead JL. Acute renal failure and open heart surgery. BMJ 1972;1:415-8.
19. Abel RM, Wick J, Beck CH Jr., et al. Renal dysfunction following open-heart operations. Arch Surg 1974;108:175-7.
20. Abel RM, Buckley MJ, Austen WG, et al. Etiology, incidence, and prognosis of renal failure following cardiac operations: results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg 1976;71:323-33.
21. Bhat JG, Gluck MC, Lowenstein J, Baldwin DS. Renal failure after open heart surgery. Ann Intern Med 1976;84:677-82.
22. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998;128:194-203.
23. Stott RB, Cameron JS, Ogg CS, Bewick M. High mortality in acute renal failure. Lancet 1972;2: 598.
24. Montgomerie JZ, Kalmanson GM, Guze LB. Renal failure and infection. Medicine (Baltimore) 1968;47:1-32.
25. Robicsek F. Effect of risk factors on the costs of coronary surgery. Am J Cardiol 2000;85:1338-9.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
27. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-9.
28. Hlatky MA, Rogers WJ, Johnstone I, et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery: Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1997;336:92-9.
29. Weintraub WS, Craver JM, Jones EL, et al. Improving cost and outcome of coronary surgery. Circulation 1998;98:II23-8.
30. Naglie G, Tansey C, Krahn MD, et al. Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65. CMAJ 1999;160:805-11.